1.
2.
The HER2+ subtype of breast cancer typically results from amplification of the proto-oncogene ERBB2, that causes overexpression of the mitogenic cell surface receptor kin [...]
2017 | Dissertation |
3.
Cancers are complex diseases that operate at multiple biological scales - from atom to organism - and the purview of cancer systems biology is to integrate information be [...]
2021 | Dissertation |
4.
Malignant brain tumors remain incurable and improving outcomes will require personalized treatment strategies. In personalized medicine, therapeutics are tailored to each [...]
2019 | Dissertation |
5.
6.
7.
The breast tumor microenvironment is a complex ecosystem of epithelial, immune, endothelial, fibroblast and adipose cells. Cellular phenotypes and spatial localizations w [...]
2022 | Thesis |
8.
This cancer cell-intrinsic GOT2-PPARδ axis promotes spatial restriction of both CD4+ and CD8+ T cells from the tumor microenvironment, and fosters the immune-suppressive [...]
2021 | Dissertation |
9.
Mechanisms of immune suppression in peripheral tissues counteract protective immu-nity to prevent immunopathology and are coopted by tumors for immune evasion. Blood and [...]
2019 | Dissertation |
10.
The inability to develop an effective anti-tumor immune response plays a key role in cancer progression. Patients with a strong anti-tumor T cell response, indicated by i [...]
2016-09-01 | Thesis |